Merck’s Former Asthma Blockbuster Singulair Could be Linked to Mental Health Problems: Reuters

A Reuters report on Friday revealed that FDA researchers have found additional molecular evidence tying blockbuster asthma therapy montelukast to adverse neuropsychiatric effects.